Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
Materials Today. Bio|April 2, 2026
Corrigendum to 'Design and <i>in vitro</i> validation of Brome mosaic -virus-like particles for gene delivery and immunomodulation of melanoma' [Mater. Today Bio <b>36</b>, February 2026, 102693, https://doi.org/10.1016/j.mtbio.2025.102693]Khalil Elbadri, Manlio Fusciello, Firas Hamdan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2012
Ad3-hTERT-E1A, a fully serotype 3 oncolytic adenovirus, in patients with chemotherapy refractory cancerOtto Hemminki, Iulia Diaconu, Vincenzo Cerullo, et al.
Human Gene Therapy|February 26, 2009
Serotype chimeric and fiber-mutated adenovirus Ad5/19p-HIT for targeting renal cancer and untargeting the liverIulia Diaconu, Laura Denby, Sari Pesonen, et al.
Clinical and Experimental Medicine|December 25, 2024
Cancer vaccines: an update on recent achievements and prospects for cancer therapyArezki Chekaoui, Mariangela Garofalo, Beata Gad, et al.
Cancer Immunology Research|September 25, 2021
β2-Integrin Adhesion Regulates Dendritic Cell Epigenetic and Transcriptional Landscapes to Restrict Dendritic Cell Maturation and Tumor RejectionCarla Guenther, Imrul Faisal, Manlio Fusciello, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2009
Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell culturesJoão D Dias, Kilian Guse, Petri Nokisalmi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 15, 2018
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped VirusesErkko Ylösmäki, Cristina Malorzo, Cristian Capasso, et al.
ACS Nano|May 18, 2019
Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint InhibitorFlavia Fontana, Manlio Fusciello, Christianne Groeneveldt, et al.
Molecular Therapy. Oncology|April 10, 2024
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapySalvatore Russo, Sara Feola, Michaela Feodoroff, et al.
Journal for Immunotherapy of Cancer|March 8, 2024
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptorsSara Feola, Firas Hamdan, Salvatore Russo, et al.
Pageof 14